In-vitro and In-vivo Evaluation of Niosomal Gel Containing Aceclofenac for Sustained Drug Delivery : Figure 11

Figure 11: In-vitro drug permeation profiles from aceclofenac niosomal and non-niosomal HPMC (3%w/w) gel formulations.